Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death. It typically causes more than one of the following: an itchy rash, throat or tongue swelling, shortness of breath, vomiting, lightheadedness, and low blood pressure. These symptoms typically come on over minutes to hours. Common allergens include pollen and certain food. Metals and other substances may also cause problems. Food, insect stings, and medications are common causes of severe reactions.
This report contains market size and forecasts of Anaphylaxis Treatment in Global, including the following market information:
Global Anaphylaxis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anaphylaxis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anaphylaxis Treatment include Pfizer, Mylan, GlaxoSmithKline, Merck, Teva Pharmaceutical and Impax Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anaphylaxis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anaphylaxis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anaphylaxis Treatment Market Segment Percentages, by Type, 2021 (%)
Oral
Parenteral
Others
Global Anaphylaxis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anaphylaxis Treatment Market Segment Percentages, by Application, 2021 (%)
Food Allergy
Pollen Allergy
Dust Mites Allergy
Others
Global Anaphylaxis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anaphylaxis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anaphylaxis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anaphylaxis Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Mylan
GlaxoSmithKline
Merck
Teva Pharmaceutical
Impax Laboratories